24 October 2017
News and Views
Links and Services
November's issue of the Alimentary Pharmacology & Therapeutics reviews coffee consumption, the metabolic syndrome and non-alcoholic fatty liver disease.
Coffee consumption may modulate the risk of the metabolic syndrome (MetS) and non-alcoholic fatty
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors